RediTrex (methotrexate) is considered a disease-modifying antirheumatic drug (DMARD). It's used to treat rheumatoid arthritis (RA), polyarticular juvenile idiopathic arthritis (pJIA), and severe psoriasis when other treatment options haven't worked well. RediTrex (methotrexate) comes as prefilled syringes, and it's injected under the skin once a week. Side effects include nausea, liver test changes, and skin sensitivity to the sun.
Rheumatoid arthritis (RA) in adults
Polyarticular juvenile idiopathic arthritis (pJIA) in children
Psoriasis in adults
RediTrex (methotrexate) is a medication that belongs under the drug class known as antimetabolites. It's also considered a disease-modifying antirheumatic drug (DMARD).
The way RediTrex (methotrexate) works to treat certain types of arthritis and psoriasis isn't completely clear. Research suggests that it helps lower the activity of the immune system to lessen inflammation. It might also help slow down the growth of skin cells.
Source: FDA
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report to your care team if they continue or are bothersome):
Only need to take once a week
Good option for people who have trouble swallowing pills
Can keep at room temperature
Many potential risks that affect many different parts of the body (e.g., lungs, liver, kidney, skin)
Might require some technique to use the prefilled syringe to inject the medication
Can't use while pregnant or breastfeeding
RediTrex (methotrexate) is injected under the skin once a week. Pick a day of the week to inject the medication that's easy for you to remember. You can put reminders on your calendar or use an app on your phone so you don't forget. This medication isn't meant to be used every day; otherwise, it could lead to serious and fatal side effects.
During treatment, make sure you get all the lab tests and scans done that your provider ordered to help check that RediTrex (methotrexate) is safe for you. This medication can cause many side effects in different parts of your body that the tests and scans can help detect.
RediTrex (methotrexate) can make you feel dizzy or tired. Be sure you know how the medication affects you before driving or operating machinery.
RediTrex (methotrexate) can make your skin more sensitive to the sun, raise your risk for sunburns, and even make previous sunburns come back. Try to avoid direct sun exposure. When you go outside, wear sunscreen and clothes that protect your skin. Let your provider know if you get a sunburn or have painful skin during treatment with RediTrex (methotrexate).
Before you get any vaccines, let your provider know that you're taking RediTrex (methotrexate). Some vaccines (e.g., live vaccines) might not work as well during treatment. Your providers can make sure the vaccine you're getting is safe for you.
Tips on how to use RediTrex (methotrexate):
Don't try to inject RediTrex (methotrexate) until you've been trained by a healthcare provider. Make sure to review the Instructions for Use, and ask your provider if you have any questions.
Before each time you use RediTrex (methotrexate), check to make sure that the solution in the prefilled syringe looks yellow and is free of particles. Air bubbles are normal. Otherwise, use another syringe.
Carefully follow the instructions to inject RediTrex (methotrexate). Remove the needle cover only when you're ready to inject. Then, inject the medication under the skin of your stomach or thigh. Make sure to avoid injecting the medication within 2 inches of your belly button or into skin that's bruised, tender, scarred, scaly, red, or hard.
Each RediTrex (methotrexate) prefilled syringe is meant for one-time use. After you've used a syringe, place it in a special sharps container for disposal. Don't throw it away in the trash. This helps prevent needle-stick injuries.
RediTrex (methotrexate) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Risk factors: Peptic ulcer disease | Ulcerative colitis | Heavy alcohol use | Kidney or liver problems| | Diabetes | Higher doses of RediTrex (methotrexate) | Taking RediTrex (methotrexate) for a long time | Taking NSAIDs | Considered obese | Fluid buildup in the body (e.g., stomach, lungs) | Older age
RediTrex (methotrexate) can cause many serious problems all over the body that can be fatal. It can put stress on your lungs, digestive tract, liver, kidneys, skin, and nervous system.
These problems can happen at any time during treatment, so your provider will follow up with you often. Your provider might also order various lab tests, tissue samples (biopsies), or scans to help check for these problems. Most symptoms can be treated if they're recognized early.
Get medical help right away if you have any of the following symptoms.
Lung problems: trouble breathing, cough
Digestive tract problems: diarrhea, vomiting, stomach pain, mouth pain or inflammation
Liver problems: yellowing of your skin or whites of the eyes, pain in the right side of your stomach, dark urine, vomiting
Kidney problems: swelling in your feet or ankles, little or no urine
Nerve problems: changes in vision, not able to move one side of your body, confusion, seizure
Rarely, RediTrex (methotrexate) can cause life-threatening allergic reactions and skin reactions. Get medical help right away if you have trouble breathing, swelling in your face or throat, rash, blisters, peeling skin, red skin, mouth sores, muscle aches, or fever.
Risk factors: Blood problems | Current infection | Weak immune system
RediTrex (methotrexate) can affect your bone marrow and cause your body to make fewer blood cells. This can cause many side effects. It can raise your chance of bleeding and make you more likely to have anemia and get infections. Your healthcare provider will probably ask to have your blood drawn periodically during treatment to check your blood cell counts. Talk to your provider right away if you suddenly have muscle weakness, unexplained bruising or bleeding, or develop a fever.
Risk factors: Pregnancy
RediTrex (methotrexate) can cause life-threatening harm to an unborn baby if it's taken during pregnancy. For this reason, avoid taking this medication if you're pregnant. If you or your partner can become pregnant, it's important for you to use birth control whenever you have sex during treatment. Continue to avoid becoming pregnant for at least 6 months (for females) and for at least 3 months (for males) after the last dose. Talk to your provider about other options if you become or would like to become pregnant.
It's possible for RediTrex (methotrexate) to make it harder for you to have children (a loss of fertility, or infertility). This medication has been linked to low sperm count and menstrual problems. This might not be reversible, so it's important that you discuss the risks with your healthcare provider if you're considering having children in the future.
Some people who took low-dose methotrexate by mouth developed certain types of cancer and tumors, such as skin cancers and blood cancers. The risk for cancer with RediTrex (methotrexate) can't be ruled out. Tell your provider if you have an unexplained fever, feel very tired, have swollen lymph nodes in your neck or armpits, or spots or moles on your skin that seem unusual.
Taking methotrexate might cause a serious condition called tumor lysis syndrome (TLS) in people who have certain cancers or tumors. Typically, people who are prescribed RediTrex (methotrexate) for arthritis or psoriasis have a low chance of developing TLS unless they have a known or undiagnosed tumor. Call your provider right away if you have nausea, vomiting, low appetite, tiredness, side pain, muscle cramps, a pounding chest, dark urine, or less urination. These can be symptoms of TLS.
Dosage | Quantity | Price as low as | Price per unit |
---|---|---|---|
4 syringes of 25mg/ml | 1 carton | $317.25 | $317.25 |
4 syringes of 7.5mg/0.3ml | 1 carton | $1037.00 | $1037.00 |
4 syringes of 10mg/0.4ml | 1 carton | $780.75 | $780.75 |
4 syringes of 12.5mg/0.5ml | 1 carton | $627.00 | $627.00 |
4 syringes of 15mg/0.6ml | 1 carton | $524.50 | $524.50 |
4 syringes of 17.5mg/0.7ml | 1 carton | $450.64 | $450.64 |
4 syringes of 20mg/0.8ml | 1 carton | $395.06 | $395.06 |
4 syringes of 22.5mg/0.9ml | 1 carton | $351.83 | $351.83 |
Dosage | Quantity | Price as low as | Price per unit |
---|---|---|---|
25mg/ml | 5 syringes | $395.06 | $79.01 |
7.5mg/0.3ml | 5 syringes | $1293.25 | $258.65 |
10mg/0.4ml | 5 syringes | $972.94 | $194.59 |
15mg/0.6ml | 5 syringes | $652.63 | $130.53 |
17.5mg/0.7ml | 5 syringes | $561.11 | $112.22 |
20mg/0.8ml | 5 syringes | $492.33 | $98.47 |
22.5mg/0.9ml | 5 syringes | $438.29 | $87.66 |
12.5/0.5ml | 5 syringes | $780.75 | $156.15 |
Rheumatoid arthritis in adults: The typical starting dose is 7.5 mg injected under the skin once a week.
Polyarticular juvenile idiopathic arthritis in children: The dose is based on body surface area (BSA), which takes into account weight and height. The typical starting dose is 10 mg/m2 injected under the skin once a week.
Psoriasis in adults: The typical starting dose ranges from 10 mg to 25 mg injected under the skin once a week.
Your provider might slowly raise your dose based on how well the medication is working for you.
Currently pregnant
Liver problems
Weak immune system
Blood problems (e.g., low platelets, low white blood cells, anemia)
Rheumatoid arthritis (RA) in adults
Polyarticular juvenile idiopathic arthritis (pJIA) in children
Psoriasis in adults
Rheumatoid arthritis (RA) in adults
Polyarticular juvenile idiopathic arthritis (pJIA) in children
Psoriasis in adults
Rheumatoid arthritis (RA) - adults only
Juvenile idiopathic arthritis (JIA) - people age 2 and older
Psoriatic arthritis (PsA) - adults only
Ankylosing spondylitis (AS) - adults only
Crohn's disease (CD) - people age 6 and older
Ulcerative colitis (UC) - people age 5 and older
Plaque psoriasis - adults only
Hidradenitis suppurativa (HS) - people age 12 and older
Uveitis - people age 2 and older
By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.
Benjamin, O., et al. (2023). Disease-modifying antirheumatic drugs (DMARD). StatPearls.
Cumberland Pharmaceuticals Inc. (2023). Reditrex (methotrexate) injection, for subcutaneous use [package insert].
Czarnecka-Operacz, M., et al. (2014). The possibilities and principles of methotrexate treatment of psoriasis - The updated knowledge. Advances in Dermatology in Allergology.
El-Esawy, F. M., et al. (2022). Methotrexate mechanism of action in plaque psoriasis: Something new in the old view. The Journal of Clinical and Aesthetic Dermatology.
Gupta, A., et al. (2018). Tumor lysis syndrome. Journal of the American Medical Association Oncology.
Hagihara, M., et al. (2018). Methotrexate-associated intravascular large B-cell lymphoma in a patient with rheumatoid arthritis: A very rare case. Internal Medicine.
OrthoInfo. (2022). Juvenile arthritis. The American Academy of Orthopaedic Surgeons.
Yan, M. K., et al. (2022). Association between low-dose methotrexate exposure and melanoma: A systematic review and meta-analysis. Journal of the American Medical Association Dermatology.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.